SHKK(600272.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
SHKK
600272.SH
Shanghai Kai Kai Industry Company Limited engages in the wholesale and retail of pharmaceutical products in China. The company is involved in the wholesale and retail of Chinese and Western medicines, prepared slices of Chinese medicinal herbs, medical devices, ginseng and tonic products, beauty and health products, and other health products and services under the Lei Yunshang brand. It also engages in the wholesale and retail of shirts, sweaters, jackets, coats, and other clothing items under the Kai Kai brand, as well as the purchase and customization of workwear. The company was founded in 1992 and is headquartered in Shanghai, China.
2.805 T
600272.SHMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking154/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE3.24%C
    • Profit Margin2.03%C
    • Gross Margin16.41%D
  • Growth ScoreC
    • Revenue YoY0.28%C
    • Net Profit YoY16.68%C
    • Total Assets YoY15.76%B
    • Net Assets YoY27.35%A
  • Cash ScoreB
    • Cash Flow Margin266.65%A
    • OCF YoY0.28%C
  • Operating ScoreB
    • Turnover0.68B
  • Debt ScoreC
    • Gearing Ratio52.78%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Pharmaceutical commercial stocks are repeatedly active, NEPTUNUS has a 6-day consecutive limit-up, Realcan hits the limit-up, HRPC, SHKK, INT'L GROUP, and others follow suit. In news, China's drug price registration system has officially launched

    Wallstreetcn·
    SH
    600829
    -2.16%
    SH
    600272
    -1.86%
    SZ
    000411
    +0.17%
    Wallstreetcn·
    SH
    600829
    -2.16%
    SH
    600272
    -1.86%
    SZ
    000411
    +0.17%

    SHKK released its performance for the first three quarters, with a net profit attributable to the parent company of 12.87 million yuan, a year-on-year decrease of 62.81%

    Zhitong·
    SH
    600272
    -1.86%
    Zhitong·
    SH
    600272
    -1.86%

    The pharmaceutical commercial sector experiences a surge, China Meheco hits the daily limit up

    Zhitong·
    SH
    600056
    -1.20%
    SZ
    301017
    -1.32%
    SH
    600272
    -1.86%
    Zhitong·
    SH
    600056
    -1.20%
    SZ
    301017
    -1.32%
    SH
    600272
    -1.86%

    SHKK released its performance for the first half of the year, with a net profit attributable to the parent company of 11.801 million yuan, a year-on-year decrease of 61.94%

    Zhitong·
    SH
    600272
    -1.86%
    SH
    900943
    -1.71%
    Zhitong·
    SH
    600272
    -1.86%
    SH
    900943
    -1.71%

    SHKK plans to publicly list and transfer 11.11% equity of Nanjing Tianshi

    Zhitong·
    SH
    600272
    -1.86%
    SH
    900943
    -1.71%
    Zhitong·
    SH
    600272
    -1.86%
    SH
    900943
    -1.71%
    © 2026 Longbridge｜Disclaimer